Literature DB >> 17180656

Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.

Yasutoshi Hida1, Yoshiaki Kubo, Kazutoshi Murao, Seiji Arase.   

Abstract

The class III histone deacetylase (HDAC), SIRT1, is a mammalian homologue of the Saccharomyces cerevisiae chromatin-silencing factor Sir2 that regulates longevity. SIRT1 regulates cell survival via deacetylation of p53 and forkhead transcription factors, and overexpression of SIRT1 is reported to be essential for cell growth and survival in some kinds of cancer. To elucidate the role of SIRT1 in human skin carcinogenesis, we have examined SIRT1 protein expression in 20 cases each of squamous cell carcinoma (SCC), basal cell carcinoma (BCC), Bowen's disease (BD), and actinic keratosis (AK) by immunohistochemical analysis. Overexpression of SIRT1 is frequently observed in all kinds of non-melanoma skin cancers included in this study. In particular, strong expression was observed in all cases of BD. In addition, no obvious difference between AK and SCC was observed in the expression of SIRT1, suggesting that overexpression of SIRT1 may have some relevance to the early stage of skin carcinogenesis. We suppose that SIRT1 could be one of the critical targets for future therapy with the aim of inhibiting cell proliferation and promoting apoptosis in non-melanoma skin cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17180656     DOI: 10.1007/s00403-006-0725-6

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  66 in total

1.  Deacetylation by SIRT1 Reprograms Inflammation and Cancer.

Authors:  Tie Fu Liu; Charles E McCall
Journal:  Genes Cancer       Date:  2013-03

Review 2.  SIRT1 and p53, effect on cancer, senescence and beyond.

Authors:  Jingjie Yi; Jianyuan Luo
Journal:  Biochim Biophys Acta       Date:  2010-05-13

3.  Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights.

Authors:  Jung-Mi Yun; Alexander Chien; Ishwarlal Jialal; Sridevi Devaraj
Journal:  J Nutr Biochem       Date:  2011-08-02       Impact factor: 6.048

Review 4.  Carcinoma of the gastroesophageal junction in Chinese patients.

Authors:  Qin Huang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

5.  Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?

Authors:  Brittney Jung-Hynes; Minakshi Nihal; Weixiong Zhong; Nihal Ahmad
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

6.  Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway.

Authors:  C-L Song; H Tang; L-K Ran; B C B Ko; Z-Z Zhang; X Chen; J-H Ren; N-N Tao; W-Y Li; A-L Huang; J Chen
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

7.  Analysis of 41 cancer cell lines reveals excessive allelic loss and novel mutations in the SIRT1 gene.

Authors:  Jeehae Han; Basil P Hubbard; Jaehoon Lee; Cristina Montagna; Han-Woong Lee; David A Sinclair; Yousin Suh
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

Review 8.  The sirtuin family's role in aging and age-associated pathologies.

Authors:  Jessica A Hall; John E Dominy; Yoonjin Lee; Pere Puigserver
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

9.  Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells.

Authors:  Vanessa Byles; Laura K Chmilewski; Joyce Wang; Lijia Zhu; Lora W Forman; Douglas V Faller; Yan Dai
Journal:  Int J Biol Sci       Date:  2010-10-07       Impact factor: 6.580

Review 10.  SIRT1, is it a tumor promoter or tumor suppressor?

Authors:  Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2009-01-21       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.